Shield Therapeutics Plc (STX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 514 | 626 | 918 | 438 | -309 |
| Accounts receivable | -8,654 | -1,142 | -7,007 | -2,797 | -3,886 |
| Other Working Capital | 5,174 | 14,580 | -7,024 | 5,983 | -2,709 |
| Other Operating Activity | -414 | -20,834 | -24,013 | -24,576 | -15,687 |
| Operating Cash Flow | $-3,380 | $-6,770 | $-37,126 | $-20,951 | $-22,590 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -35 | -239 | -64 | -502 |
| Purchase Sale Intangibles | N/A | N/A | 0 | 0 | -12 |
| Other Investing Activity | -185 | -2,120 | -2,191 | -2,193 | -2,254 |
| Investing Cash Flow | $-209 | $-2,155 | $-2,430 | $-2,257 | $-2,768 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,708 | 0 | 29,446 | 9,112 | N/A |
| Debt Repayment | N/A | 0 | -5,448 | N/A | N/A |
| Common Stock Issued | 11,954 | 122 | 26,817 | 105 | 37,392 |
| Common Stock Repurchased | N/A | N/A | 0 | -99 | N/A |
| Other Financing Activity | -5,034 | 1,305 | -1,159 | -638 | -163 |
| Financing Cash Flow | $8,628 | $1,427 | $49,656 | $8,480 | $37,228 |
| Exchange Rate Effect | 58 | 74 | 446 | 3,478 | 516 |
| Beginning Cash Position | 6,524 | 13,948 | 3,402 | 14,664 | 3,968 |
| End Cash Position | 11,621 | 6,524 | 13,948 | 3,414 | 16,354 |
| Net Cash Flow | $5,039 | $-7,498 | $10,100 | $-14,728 | $11,870 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,380 | -6,770 | -37,126 | -20,951 | -22,590 |
| Capital Expenditure | -300 | -2,421 | -2,948 | -2,293 | -2,786 |
| Free Cash Flow | -3,680 | -9,191 | -40,074 | -23,244 | -25,376 |